This document discusses mitigating the risk of droplet dispersion when using non-invasive ventilation (NIV) during the COVID-19 pandemic. It references several studies and guidelines on aerosolization risks from NIV and other respiratory therapies. The document aims to provide guidance on safer NIV use to reduce transmission of airborne infections like COVID-19.